Shots:

• The US FDA has approved Abbott’s Portico with FlexNav TAVR system to treat patients with symptomatic- severe aortic stenosis who are at high or extreme risk for open-heart surgery. The system provides a safe & effective treatment option
• Abbott’s Portico is a self-expanding TAVR valve with an intra-annular leaflet that is designed to provide optimal blood flow when placed inside a patient’s natural valve
• Portico device is implanted using Abbott's FlexNav delivery system to accommodate different patient anatomies- small vessels- flexibility- tracking & precision of valve placement. Abbott offers a robust portfolio of structural heart solutions in the US including minimally invasive therapies

  | Ref: Abbott | Image:Abbott